Tatiana J. Carneiro's academic career is based in the Biochemistry field. She concluded the BSc degree in 2015 and the MSc degree in Biomolecular Methods in 2017, both at University of Aveiro, with scientific work developed within the scope of metabolomics. In 2018, she worked as a research fellow on the BioIMPACT project, which aimed to evaluate the metabolic impact of new-synthetized complex Palladium(II)-spermine as a potential antineoplastic agent with lower cytotoxicity than the conventional drug cisplatin. From 2019, she is a PhD student of Biochemistry at the University of Aveiro, focusing on identifying biomarkers of the in vitro and in vivo metabolic impact of metal-based drugs, as potential new low-toxic therapeutic agents against triple-negative breast cancer. Single-drug protocols and combination with Gemcitabine will be performed to account for drug synergism, hoping to reveal promising alternatives to the current chemotherapeutic drugs. This work developed until the present has led to the publication of six peer-reviewed papers, with Tatiana J. Carneiro as the first author, enriching her publications list.